MiRus
Healthcare · Hardware
MiRus locks in $1.5B strategic round, hits $4.41B valuation
July 9, 2026$1.5B · late-stage strategic round
HealthTech device maker MiRus secured a $1.5B late-stage strategic round from Boston Scientific, lifting its valuation to about $4.41B.
Lead Investors
Boston Scientific
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.